Transactions

uniQure’s License Agreement with CSL Behring to Commercialize Hemophilia B Gene Therapy

Date Announced:
06/24/2020

client:
uniQure N.V.

Status:
Pending

Value:
$2+ billion

Clear all

Download CSV